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Thrombosis – prevention is better than cure
Thrombosis is the biggest killer internationally.[1] Lack of appropriate 
education means that this fact is little known, and it is also eclipsed 
in the public eye by the much wider awareness of malignant tumours. 
While cancer is indeed a justly feared killer, the true prevalence of 
thrombosis and the devastation that it causes deserve to be far better 
recognised. Heart attacks and strokes are responsible for most deaths 
worldwide.[1] Venous thromboembolism (VTE) is the most important 
preventable cause of deaths in hospital. There is strong evidence that 
prophylaxis remains underprescribed.[2]
In an attempt to address this problem, guidelines have been 
produced internationally. Some of them have failed, not only because 
of the requirement for evidence-based decisions but because in 
attempting to target specialists they have been cumbersome and 
impractical, and the ordinary prescribing doctor is overawed and 
unable to extract the critical essence. The first American College of 
Chest Physicians guideline is a prime example – it was an excellent 
guideline, but too comprehensive and impractical to use.[3]
The Southern African Society of Thrombosis and Haematology 
produced the first South African guideline, which was published in the 
SAMJ in 2004.[4] The guideline was updated in June 2009,[5] and the most 
recent update is published in this issue of the journal. It was designed 
to be a practical and concise guideline that can be utilised by general 
practitioners and specialists alike. Once again it is evidence based, and 
it has been reviewed by two independent internationally recognised 
experts in the field. The guideline includes only registered indications at 
the time of submission. It covers how to use the new oral anticoagulants, 
and also provides an approach to managing complications. 
The guideline has been endorsed by the Southern African Society 
of Anaesthetists, the Critical Care Society of Southern Africa, 
the Faculty of Consulting Physicians, the South African Society 
of Haematology, the South African Society of Obstetricians and 
Gynaecologists, the South African Orthopaedic Association, the 
South African Heart Association, the Neurology Society of South 
Africa and the South African Renal Consortium. We hope that it will 
improve VTE prophylaxis in southern Africa.
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